5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results